As of Apr 20
| +0.0022 / +0.97%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 0.40, with a high estimate of 0.40 and a low estimate of 0.40. The median estimate represents a +73.83% increase from the last price of 0.23.
The current consensus among 1 polled investment analysts is to Hold stock in OHR Pharmaceutical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.